Variable | No. observations (n = 410) § | Streptococcus pneumoniae | Staphylococcus aureus | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
No. isolates (n = 173)φ | OR [95% CI] | p | Adjusted OR [95% CI] | p | No. isolates (n = 86)λ | OR [95% CI] | p | Adjusted OR [95% CI] | p | ||
Group | |||||||||||
 CLD- | 18% (74) | 11% (19) | Reference |  | Reference |  | 10% (9) | Reference |  | Reference |  |
 CLD+ | 82% (336) | 89% (154) | 2.5 [1.4–4.4] | 0.002 | 2.0[1.1–3.9] | 0.04 | 90% (77) | 2.2 [1.1–4.8] | 0.04 | 1.8 [0.8–4.5] | 0.17 |
Study site | |||||||||||
 Malawi | 28% (114) | 32% (56) | Reference |  | Reference |  | 31% (27) | Reference |  | Reference |  |
 Zimbabwe | 72% (296) | 68% (117) | 0.7 [0.4–1.1] | 0.08 | 1.3 [0.7–2.4] | 0.42 | 69% (59) | 0.8 [0.5–1.4] | 0.40 | 0.7 [0.4–1.5] | 0.39 |
Sex | |||||||||||
 Female | 52% (212) | 54% (94) | Reference |  | Reference |  | 41% (35) | Reference |  | Reference |  |
 Male | 48% (198) | 46% (79) | 0.8 [0.6–1.2] | 0.36 | 0.7 [0.4–1.0] | 0.07 | 59% (51) | 1.8 [1.1–2.9] | 0.02 | 1.7 [1.0–2.9] | 0.05 |
Season of sample collection | |||||||||||
 Dec - Apr - Rainy season | 36% (149) | 32% (56) | Reference |  | Reference |  | 36% (31) | Reference |  | Reference |  |
 May–Aug - Cool season | 39% (160) | 43% (74) | 1.4 [0.9–2.3] | 0.30 | 1.7 [1.0–2.9] | 0.13 | 29% (25) | 0.7 [0.4–1.3] | 0.03 | 0.9 [0.5–1.6] | 0.11 |
 Sep - Nov - Hot season | 25% (101) | 25% (43) | 1.2 [0.7–2.1] | 1.3 [0.7–2.3] | 35% (30) | 1.6 [0.9–2.9] | 1.7 [0.9–3.2] | ||||
Enrolment age category | |||||||||||
 17-19y | 32% (131) | 20% (35) | Reference |  | Reference |  | 28% (24) | Reference |  | Reference |  |
 13-16y | 41% (168) | 47% (81) | 2.6 [1.6–4.2] | <0.001 | 2.2 [1.3–3.8] | <0.001 | 43% (37) | 1.3 [0.7–2.3] | 0.66 | 1.1 [0.6–2.1] | 0.83 |
 6-12y | 27% (111) | 33% (57) | 2.9 [1.7–5.0] | 3.2 [1.8–5.8] | 29% (25) | 1.3 [0.7–2.4] | 1.2 [0.6–2.5] | ||||
Number of years on ART | |||||||||||
 6 m- < 2y | 9% (35) | 14% (23) | Reference |  | Reference |  | 7% (6) | Reference |  | Reference |  |
 2- < 4y | 18% (72) | 18% (30) | 0.4 [0.2–0.9] | 0.02 | 0.4 [0.2–1.0] | 0.04 | 18% (15) | 1.3 [0.5–3.9] | 0.94 | 1.2 [0.4–3.9] | 0.78 |
 4y- < 6y | 20% (81) | 22% (36) | 0.4 [0.2–0.9] | 0.4 [0.2–1.0] | 22% (18) | 1.4 [0.5–4.1] | 1.4 [0.5–4.4] | ||||
 6y+ | 53% (214) | 47% (78) | 0.3 [0.1–0.6] | 0.3 [0.1–0.7] | 53% (44) | 1.3 [0.5–3.5] | 1.0 [0.4–3.0] | ||||
CD4 count | |||||||||||
  > 500 | 63% (257) | 62% (108) | Reference |  |  |  | 63% (54) | Reference |  |  |  |
 200–500 | 27% (112) | 24% (42) | 0.8 [0.5–1.3] | 0.09 |  |  | 30% (26) | 1.1 [0.7–1.9] | 0.55 |  |  |
  < 200 | 10% (40) | 13% (23) | 1.9 [1.0–3.7] |  |  | 7% (6) | 0.7 [0.2–1.6] |  |  | ||
Enrolment viral load | |||||||||||
 Unsuppressed | 42% (174) | 46% (80) | Reference |  | Reference |  | 55% (47) | Reference |  | Reference |  |
 Suppressed | 58% (236) | 54% (93) | 0.8[0.5–1.1] | 0.18 | 0.6 [0.4–1.0] | 0.03 | 45% (39) | 0.5 [0.3–0.9] | 0.01 | 0.5 [0.3–0.9] | 0.02 |
ART regimen | |||||||||||
 PI-based regimen - 2nd line | 24% (98) | 25% (44) | Reference |  | Reference |  | 33% (28) | Reference |  | Reference |  |
 NNRTI-based regimen -1st line | 76% (312) | 75% (129) | 0.9 [0.6–1.4] | 0.55 | 0.8 [0.5–1.4] | 0.44 | 67% (58) | 0.6 [0.3–1.0] | 0.03 | 0.6 [0.3–1.1] | 0.07 |
Ever treated for TB | |||||||||||
 No | 74% (302) | 70% (120) | Reference |  | Reference |  | 71% (61) | Reference |  | Reference |  |
 Yes | 26% (106) | 30% (52) | 1.5 [0.9–2.3] | 0.10 | 1.5 [0.9–2.5] | 0.12 | 29% (25) | 1.2 [0.7–2.1] | 0.46 | 0.9 [0.5–1.7] | 0.83 |
Enrolment weight- for-age- z-score | |||||||||||
 Not underweight | 54% (220) | 49% (85) | Reference |  |  |  | 49% (42) | Reference |  |  |  |
 Underweight | 46% (190) | 51% (88) | 1.4 [0.9–2.0] | 0.12 |  |  | 51% (44) | 1.3 [0.8–2.1] | 0.31 |  |  |
Enrolment height-for-age- z-score - | |||||||||||
 Not stunted | 54% (220) | 45% (78) | Reference |  | Reference |  | 52% (45) | Reference |  | Reference |  |
 Stunted | 46% (190) | 55% (95) | 1.8 [1.2–2.7] | 0.003 | 1.6 [1.1–2.6] | 0.03 | 48% (41) | 1.1 [0.7–1.7] | 0.78 | 0.8 [0.5–1.3] | 0.39 |
Ever repeated a grade | |||||||||||
 No | 46% (183) | 41% (69) | Reference |  |  |  | 42% (36) | Reference |  |  |  |
 Yes | 54% (218) | 59% (100) | 1.4 [0.9–2.1] | 0.10 |  |  | 58% (49) | 1.2 [0.7–1.9] | 0.49 |  |  |
MRC dyspnoea score | |||||||||||
 1 or 0 | 60% (244) | 53% (91) | Reference |  | Reference |  | 56% (48) | Reference |  | Reference |  |
  > 1 | 40% (165) | 47% (81) | 1.6 [1.1–2.4] | 0.02 | 1.3 [0.7–2.2] | 0.36 | 44% (37) | 1.2 [0.7–1.9] | 0.50 | 1.0 [0.5–1.8] | 0.94 |